Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

Setsuko K. Chambers

doi:10.3390/cancers14205020

Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

Setsuko K. Chambers

Research output: Contribution to journal › Comment/debate › peer-review

10 Scopus citations

Abstract

Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access.

Original language	English (US)
Article number	5020
Journal	Cancers
Volume	14
Issue number	20
DOIs	https://doi.org/10.3390/cancers14205020
State	Published - Oct 2022

Keywords

endometrial cancer
molecular subtyping
targeted therapy

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3390/cancers14205020

Cite this

@article{32c6f12237654e8f95b37e343df522b7,

title = "Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer",

abstract = "Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access.",

keywords = "endometrial cancer, molecular subtyping, targeted therapy",

author = "Chambers, \{Setsuko K.\}",

note = "Publisher Copyright: {\textcopyright} 2022 by the author.",

year = "2022",

month = oct,

doi = "10.3390/cancers14205020",

language = "English (US)",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "20",

}

TY - JOUR

T1 - Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

AU - Chambers, Setsuko K.

PY - 2022/10

Y1 - 2022/10

N2 - Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access.

AB - Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other cancers that share similar molecular typing, and hence, potentially similar tumor behavior. This commentary serves as a broad overview of the types of advances to which our patients now have access.

KW - endometrial cancer

KW - molecular subtyping

KW - targeted therapy

UR - https://www.scopus.com/pages/publications/85140487428

UR - https://www.scopus.com/pages/publications/85140487428#tab=citedBy

U2 - 10.3390/cancers14205020

DO - 10.3390/cancers14205020

M3 - Comment/debate

AN - SCOPUS:85140487428

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 20

M1 - 5020

ER -

Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this